Poor prognosis indicated by nucleated red blood cells in peripheral blood is not associated with organ failure of the liver or kidney : Clinical Chemical Laboratory Medicine Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2014: 0.741
Source Normalized Impact per Paper (SNIP) 2014: 1.011
Impact per Publication (IPP) 2014: 2.310

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue
Loading journal volume and issue information...

30,00 € / $42.00 / £23.00

Get Access to Full Text

Poor prognosis indicated by nucleated red blood cells in peripheral blood is not associated with organ failure of the liver or kidney

Axel Stachon1 / Tim Holland-Letz2 / Reiner Kempf3 / Andreas Becker4 / Jochen Friese5 / Michael Krieg6

1.

2.

3.

4.

5.

6.

Corresponding author: PD Dr. med. Axel Stachon, Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, BG-University Hospital Bergmannsheil, Ruhr-University, Buerkle-de-la-Camp-Platz 1, 44789 Bochum, Germany Phone: +49-234-3020, Fax: +49-234-302-6614,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 44, Issue 8, Pages 955–961, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2006.183, August 2006

Publication History

Received:
March 24, 2006
Accepted:
May 18, 2006

Abstract

Background: The appearance of nucleated red blood cells (NRBCs) in peripheral blood is associated with a variety of severe diseases. When NRBCs are detected in blood, this is generally associated with increased mortality.

Methods: In a prospective study, NRBCs and other laboratory parameters were measured daily in the peripheral blood of surgical intensive care patients. The appearance of NRBCs was analyzed in relation to laboratory indicators of organ injury.

Results: A total of 284 surgical intensive care patients were included in this study. The mortality of NRBC-positive patients was 44.0% (40/91). This was significantly higher (p<0.001) than the mortality of NRBC-negative patients (4.2%, 8/193). Mortality increased with the NRBC concentration and the length of the NRBC-positive period. Multiple logistic regression analysis of several other clinical and laboratory risk indicators revealed a significant association between NRBCs and increased mortality, with an odds ratio of 1.95 (95% CI 1.35–2.82; p<0.001) for each increment in NRBC category (0, 1–40, 41–80, 81–240 and >240 NRBC/μL). After the initial detection of NRBCs in blood, there were no significant increases in creatinine concentrations or alanine aminotransferase activity. However, the appearance of NRBCs coincided with increasing C-reactive protein and thrombocyte concentrations.

Conclusions: The detection of NRBCs in blood of surgical intensive care patients is of prognostic power with regard to patient mortality. This prognostic significance of NRBCs was independent of some clinical and other laboratory risk parameters. The appearance of NRBCs in blood was not associated with kidney failure or lesion of the liver.

Clin Chem Lab Med 2006;44:955–61.

Keywords: mortality; nucleated red blood cells; organ failure

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Sapana Desai, Stephen L. Jones, Krista L. Turner, Jeff Hall, and Laura J. Moore
Surgical Infections, 2012, Volume 13, Number 6, Page 360
[2]
Sandra Kuert, Tim Holland-Letz, Jochen Friese, and Axel Stachon
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 2
[3]
Axel Stachon, Andreas Becker, Reiner Kempf, Tim Holland-Letz, Jochen Friese, and Michael Krieg
The Journal of Trauma: Injury, Infection, and Critical Care, 2008, Volume 65, Number 3, Page 666
[4]
A. Stachon, A. Becker, T. Holland-Letz, J. Friese, R. Kempf, and M. Krieg
European Surgical Research, 2008, Volume 40, Number 3, Page 263

Comments (0)

Please log in or register to comment.